Zydus Lifesciences Limited (BOM:532321)
India flag India · Delayed Price · Currency is INR
904.85
-15.95 (-1.73%)
At close: Feb 13, 2026

Zydus Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
910,340891,9261,013,630497,549356,774451,368
Market Cap Growth
-1.94%-12.01%103.72%39.46%-20.96%64.98%
Enterprise Value
963,895892,1811,022,435525,557387,118504,363
Last Close Price
904.85875.67991.39480.25338.29425.19
PE Ratio
18.4319.7126.2625.387.9521.16
PS Ratio
3.493.845.192.892.363.13
PB Ratio
3.243.384.592.531.873.02
P/TBV Ratio
9.755.768.484.283.407.04
P/FCF Ratio
-17.6144.2730.0139.5618.50
P/OCF Ratio
-13.1631.7118.5016.9513.70
EV/Sales Ratio
3.693.845.233.052.563.50
EV/EBITDA Ratio
13.0513.0619.4514.8712.2114.77
EV/EBIT Ratio
15.0914.9722.5318.4215.6518.44
EV/FCF Ratio
-17.6244.6531.7042.9220.67
Debt / Equity Ratio
0.340.120.040.060.220.31
Debt / EBITDA Ratio
1.320.470.160.341.331.35
Debt / FCF Ratio
-0.640.360.724.681.89
Net Debt / Equity Ratio
0.09-0.09-0.0200.010.24
Net Debt / EBITDA Ratio
0.35-0.35-0.100.000.081.03
Net Debt / FCF Ratio
--0.48-0.230.000.271.45
Asset Turnover
-0.700.710.640.590.61
Inventory Turnover
-1.771.871.811.641.64
Quick Ratio
-1.121.301.050.960.57
Current Ratio
-1.892.141.811.541.11
Return on Equity (ROE)
-19.28%18.90%10.82%13.96%16.91%
Return on Assets (ROA)
-11.21%10.31%6.66%5.98%7.19%
Return on Invested Capital (ROIC)
15.34%20.11%17.64%11.43%10.78%13.64%
Return on Capital Employed (ROCE)
-21.20%19.00%14.10%12.40%17.10%
Earnings Yield
5.42%5.07%3.81%3.94%12.58%4.73%
FCF Yield
-5.68%2.26%3.33%2.53%5.41%
Dividend Yield
1.24%1.26%0.30%1.25%0.74%0.82%
Payout Ratio
-6.68%16.09%13.63%8.29%0.07%
Buyback Yield / Dilution
0.11%0.56%0.37%0.79%--
Total Shareholder Return
1.35%1.82%0.67%2.04%0.74%0.82%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.